Free Access to TSR Screeners - Sign Up for Your Nightly Pass
EBITDA Margin ratio Analysis of Akums Drugs and Pharmaceuticals Ltd. - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPoint
Beta&Vols
Tech ChartsLatest FY EBITDA Margin
Period Ending - Mar-25
Indecisive EBITDA Margin
12.95
Period Ending - Mar-24
Poor EBITDA Margin
3.13
Growth
313.13 %
Trailing Twelve Months EBITDA Margin
Period Ending - Mar-25
Indecisive EBITDA Margin
13.07
Most recent Quarter EBITDA Margin
Period Ending - Sep-25
Indecisive EBITDA Margin
12.28
EBITDA Margin Analysis of Akums Drugs and Pharmaceuticals Ltd.
| EBITDA Margin Ratio of AKUMS rose handsomely by 313.13 % this year. |
Other EBITDA Margin Related Info of AKUMS that may interest you.
Akums Drugs and Pharmaceuticals Ltd. Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| AKUMS | 425.95 | 421.60 | 1.03 % | Drugs & Pharma |
Defination of EBITDA Margin
EBITDA Margin is the profitability ratio that measures a company's earnings before interest, taxes, depreciation, and amortization as a percentage of revenue. EBITDA is the abbreviation for Earnings before Interest, Taxes, Depreciation, and Amortization. more ..
EBITDA Margin Related Ratios
| NetProfitMargin | ReturnOnEquity |
Tsr Profitability Index
| Very Low Profitability Stock | Screener |
FY - Historical EBITDA Margin of Akums Drugs and Pharmaceuticals Ltd.
| Period | Mar-25 | Mar-24 | Mar-23 | Mar-22 |
|---|---|---|---|---|
| EBITDA Margin | 12.95 | 3.13 | 8.47 | -2.23 |
| Change | 313.13 % | -62.99 % | 479.00 % | |
| Price | 473.20 | 0 | 0 | 0 |
| Price Change |